Skip to main content
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · IEX Real-Time Price · USD
10.54
+0.09 (0.91%)
At close: Jul 19, 2024, 4:00 PM
11.00
+0.46 (4.36%)
Pre-market: Jul 22, 2024, 7:01 AM EDT

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $10.00K in the twelve months ending March 31, 2024. In the year 2023, ARS Pharmaceuticals had annual revenue of $30.00K.

Revenue (ttm)
$10.00K
Revenue Growth
-98.51%
P/S Ratio
102,127.65
Revenue / Employee
$385
Employees
26
Market Cap
1.02B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.00K-1.29M-97.72%
Dec 31, 20221.32M-4.19M-76.10%
Dec 31, 20215.51M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OPKO Health 799.60M
Avanos Medical 680.10M
BioLife Solutions 137.30M
Calliditas Therapeutics AB (publ) 119.73M
Tarsus Pharmaceuticals 42.56M
Tango Therapeutics 37.23M
Revenue Rankings

SPRY News

More News